TRAW · Traws Pharma, Inc.
$0.57
-0.03 (-4.83%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern through the one-year period after the date that the financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$8.78M
Shares
15.37M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
582,837
-7.1% vs reported
Short Squeeze Score
52/100
Short interest 4.1% of shares — P68
Days to cover 5.6 — P72
Price vs VWAP -51.5% — P3
Short-volume trend -5.3% — P30
Short interest change -10.4% — P27
Worst FTD 9.18% of shares — P99
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 627,168 | 699,850 | -72,682 | 5.55 |
| 2026-07-15 | 699,850 | 980,144 | -280,294 | 3.82 |
| 2026-06-30 | 980,144 | 1,134,900 | -154,756 | 3.02 |
| 2026-06-15 | 1,134,900 | 1,375,032 | -240,132 | 1.62 |
| 2026-05-29 | 1,375,032 | 1,671,345 | -296,313 | 1.95 |
| 2026-05-15 | 1,671,345 | 560,036 | +1,111,309 | 1.00 |
| 2026-04-30 | 560,036 | 405,599 | +154,437 | 1.78 |
| 2026-04-15 | 405,599 | 411,637 | -6,038 | 2.05 |
| 2026-03-31 | 411,637 | 456,663 | -45,026 | 8.78 |
| 2026-03-13 | 456,663 | 519,827 | -63,164 | 4.36 |
| 2026-02-27 | 519,827 | 526,505 | -6,678 | 4.11 |
| 2026-02-13 | 526,505 | 505,708 | +20,797 | 3.89 |
| 2026-01-30 | 505,708 | 531,738 | -26,030 | 1.29 |
| 2026-01-15 | 531,738 | 257,978 | +273,760 | 1.50 |
| 2025-12-31 | 257,978 | 175,604 | +82,374 | 1.00 |
| 2025-12-15 | 175,604 | 291,860 | -116,256 | 1.00 |
| 2025-11-28 | 291,860 | 74,142 | +217,718 | 1.24 |
| 2025-11-14 | 74,142 | 54,098 | +20,044 | 1.00 |
| 2025-10-31 | 54,098 | 74,502 | -20,404 | 1.00 |
| 2025-10-15 | 74,502 | 134,747 | -60,245 | 1.00 |
| 2025-09-30 | 134,747 | 119,973 | +14,774 | 2.05 |
| 2025-09-15 | 119,973 | 102,595 | +17,378 | 1.05 |
| 2025-08-29 | 102,595 | 162,903 | -60,308 | 1.09 |
Showing 1–23 of 23 settlements
Key facts
CIK
1130598
CUSIP
68232V884
13F (30d)
39 filings
38 filers
Visit website
Investor relations